IQS-019

N/A

Report date: 2023/04/02 18:56:02
NME

Base Information

Drug NameIQS-019
Drug Alias NameIQS-019
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitorsTyrosine-protein kinase BTK inhibitorsTyrosine-protein kinase Lyn inhibitors
TargetsTyrosine-protein kinase LynTyrosine-protein kinase BTKSpleen tyrosine kinase
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIdibaps - Institut D'Investigacions Biomèdiques August Pi I Sunyer
China Registration ClassN/A

Develop Information

Active CompaniesIdibaps - Institut D'Investigacions Biomèdiques August Pi I Sunyer
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A